Dimensional Fund Advisors LP Reduces Stock Holdings in Orthofix Medical Inc. (NASDAQ:OFIX)

Dimensional Fund Advisors LP reduced its position in Orthofix Medical Inc. (NASDAQ:OFIX) by 17.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 281,403 shares of the medical device company’s stock after selling 61,239 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.75% of Orthofix Medical worth $3,732,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Orthofix Medical by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 2,008,816 shares of the medical device company’s stock worth $29,168,000 after acquiring an additional 9,150 shares during the last quarter. Glenview Capital Management LLC purchased a new stake in shares of Orthofix Medical during the fourth quarter worth $6,740,000. Boone Capital Management LLC bought a new position in shares of Orthofix Medical in the fourth quarter worth $6,740,000. Great Lakes Advisors LLC grew its position in shares of Orthofix Medical by 15.1% in the second quarter. Great Lakes Advisors LLC now owns 259,750 shares of the medical device company’s stock valued at $3,444,000 after purchasing an additional 34,114 shares in the last quarter. Finally, Mutual of America Capital Management LLC raised its stake in shares of Orthofix Medical by 15.3% during the 1st quarter. Mutual of America Capital Management LLC now owns 175,671 shares of the medical device company’s stock valued at $2,551,000 after purchasing an additional 23,324 shares during the period. 89.76% of the stock is currently owned by institutional investors.

Orthofix Medical Stock Down 0.5 %

Shares of NASDAQ OFIX opened at $15.00 on Friday. The business has a 50-day simple moving average of $16.21 and a two-hundred day simple moving average of $14.86. The company has a quick ratio of 1.13, a current ratio of 2.48 and a debt-to-equity ratio of 0.24. Orthofix Medical Inc. has a 52 week low of $9.57 and a 52 week high of $17.67. The company has a market cap of $562.94 million, a P/E ratio of -4.44 and a beta of 1.05.

Orthofix Medical (NASDAQ:OFIX) last posted its quarterly earnings data on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.30) by ($0.58). Orthofix Medical had a negative return on equity of 20.68% and a negative net margin of 15.61%. The company had revenue of $198.62 million during the quarter, compared to the consensus estimate of $195.75 million. Research analysts anticipate that Orthofix Medical Inc. will post -2.13 earnings per share for the current fiscal year.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.